Home/Filings/4/0001128732-19-000025
4//SEC Filing

Sebaaly Camille 4

Accession 0001128732-19-000025

CIK 0001402328other

Filed

Sep 22, 8:00 PM ET

Accepted

Sep 23, 9:56 AM ET

Size

6.5 KB

Accession

0001128732-19-000025

Insider Transaction Report

Form 4
Period: 2019-09-02
Sebaaly Camille
DirectorCFO and Secretary
Transactions
  • Award

    Common Stock

    2019-09-02$0.00/sh+13,000,000$13,00018,861,719 total
  • Award

    Common Stock

    2019-09-11$0.00/sh+11,000,000$11,00029,861,719 total
Footnotes (1)
  • [F1]Effective February 1, 2019, Issuer effectuated a reverse stock split wherein 1 share of Common Stock was issued for each 20 shares of the issued and outstanding Common Stock of the Issuer resulting in Reporting Person owning 5,861,719 shares of Common Stock of the Issuer as of that date.

Issuer

Sunshine Biopharma, Inc

CIK 0001402328

Entity typeother

Related Parties

1
  • filerCIK 0001474695

Filing Metadata

Form type
4
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 9:56 AM ET
Size
6.5 KB